CHMP-EMA Approves Darzalex (Daratumumab) as First Self-administered Oncology Injectable for Patients or Caregivers (https://www.myeloma.org/news-events/multiple-myeloma-news/chmp-ema-approves-dara-as-first-self-administered-oncology-injectable)